Trump's tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks

3 weeks ago 4

Published Tue, Apr 1 20252:01 PM EDTUpdated Tue, Apr 1 20253:04 PM EDT

Read Entire Article
  1. Homepage
  2. Health
  3. Trump's tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks

Related

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly sues four telehealth sites selling compounded Zepb...

1 day ago 1
FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks

FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles ...

1 day ago 6
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma

Healthy Returns: Trump seeks to change Medicare drug price n...

1 day ago 4
Danaher's quarterly results show signs of life, and the struggling stock soars

Danaher's quarterly results show signs of life, and the stru...

1 day ago 4

Trending

1. brazil
2. iga świątek
3. judge royce lamberth
4. cep stock
5. all things go nyc
6. alexandra eala
7. canadian snowbirds florida
8. shrinking
9. cz shadow 2 carry
10. joseph kling

Popular

This fund is designed to help investors withstand wild market swings

This fund is designed to help investors withstand wild marke...

5 days ago 29
Luka Doncic opens up about trade: ‘My heart was broken, I smashed my phone’

Luka Doncic opens up about trade: ‘My heart was broken, I sm...

4 days ago 27
I'm a dietitian who practices 'stress-free eating': These are the foods I eat every week—'I try for a balanced plate'

I'm a dietitian who practices 'stress-free eating': These ar...

5 days ago 27
Look inside: We spent $64 million turning an old Virginia prison into an apartment complex— 'it's important to preserve history'

Look inside: We spent $64 million turning an old Virginia pr...

5 days ago 19
Iran and the U.S. move to expert-level talks over Tehran's nuclear program after negotiations in Rome

Iran and the U.S. move to expert-level talks over Tehran's n...

4 days ago 19
English (US) English (US)
About Us · Contact Us · Terms & Conditions ·

© Mova 2025. All rights are reserved